The Combined Use of Platelet-Rich Plasma Clot Releasate and Allogeneic Human Umbilical Cord Mesenchymal Stem Cells Rescue Glucocorticoid-Induced Osteonecrosis of the Femoral Head
Glucocorticoid-induced osteonecrosis of the femoral head (ONFH) is a refractory disease. The treatment options for ONFH, especially nonsurgical ones, merit further investigation. To evaluate the combinatorial therapeutic effects of platelet-rich plasma clot releasate (PRCR) and umbilical cord mesenc...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Stem Cells International |
| Online Access: | http://dx.doi.org/10.1155/2022/7432665 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832562523284439040 |
|---|---|
| author | Yanxue Wang Shuo Luan Ze Yuan Shaoling Wang Shengnuo Fan Chao Ma Shaoling Wu |
| author_facet | Yanxue Wang Shuo Luan Ze Yuan Shaoling Wang Shengnuo Fan Chao Ma Shaoling Wu |
| author_sort | Yanxue Wang |
| collection | DOAJ |
| description | Glucocorticoid-induced osteonecrosis of the femoral head (ONFH) is a refractory disease. The treatment options for ONFH, especially nonsurgical ones, merit further investigation. To evaluate the combinatorial therapeutic effects of platelet-rich plasma clot releasate (PRCR) and umbilical cord mesenchymal stem cells (UC-MSCs) on glucocorticoid-induced ONFH, a dexamethasone (DEX)-treated cell model and a high-dose methylprednisolone (MPS)-treated rat model were established. Cell counting kit-8 (CCK-8) assay was performed in vitro to determine the optimum dosage of PRCR for UC-MSC viability. The effects of PRCR, UC-MSCs, and PRCR + UC-MSCs on cell viability, apoptosis, migration, and differentiation capacities of DEX-treated bone marrow mesenchymal stem cells (BMSCs) and human umbilical vein endothelial cell (HUVECs) were explored via Transwell assays. Western blotting was conducted to evaluate the expression levels of RUNX2, VEGF, caspase-3, and Bcl-2 in the coculture systems. Ultrasound-guided intra-articular PRCR, UC-MSCs, and PRCR + UC-MSC injections were performed on the ONFH model rats. Microcomputed tomography, histological and immunohistochemical analyses, tartrate-resistant acid phosphatase (TRAP) staining, and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining were used to assess the therapeutic effects of PRCR and UC-MSCs on bone loss and necrosis induced by high-dose MPS. Results of this study revealed that the in vitro application of PRCR, UC-MSCs, and PRCR + UC-MSCs reversed the impaired proliferation and migration capacities and resisted apoptosis of BMSCs and HUVECs induced by DEX. Moreover, the PRCR and UC-MSC application significantly improved the alkaline phosphatase (ALP) and alizarin red (ALR) staining of BMSCs and tube formation capacity of HUVECs and promoted the protein expression of RUNX2 in BMSCs and VEGF in HUVECs. Similarly, in the ONFH rat model, the intra-articular injection of UC-MSCs and PRCR improved the subchondral bone mass parameters; promoted the expression of ALP, RUNX2, and VEGF; suppressed osteoclast overactivity; and resisted cell apoptosis. The combination of PRCR and UC-MSCs shows promising therapeutic effects in treating glucocorticoid-induced ONFH. The current study provides important information on intra-articular therapy, paving the way for the clinical management of ONFH in the future. |
| format | Article |
| id | doaj-art-38aa545c9a524475b4c5e7c27749f0bb |
| institution | Kabale University |
| issn | 1687-9678 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Stem Cells International |
| spelling | doaj-art-38aa545c9a524475b4c5e7c27749f0bb2025-02-03T01:22:26ZengWileyStem Cells International1687-96782022-01-01202210.1155/2022/7432665The Combined Use of Platelet-Rich Plasma Clot Releasate and Allogeneic Human Umbilical Cord Mesenchymal Stem Cells Rescue Glucocorticoid-Induced Osteonecrosis of the Femoral HeadYanxue Wang0Shuo Luan1Ze Yuan2Shaoling Wang3Shengnuo Fan4Chao Ma5Shaoling Wu6Department of Rehabilitation MedicineDepartment of Rehabilitation MedicineDepartment of Rehabilitation MedicineDepartment of Rehabilitation MedicineDepartment of Rehabilitation MedicineDepartment of Rehabilitation MedicineDepartment of Rehabilitation MedicineGlucocorticoid-induced osteonecrosis of the femoral head (ONFH) is a refractory disease. The treatment options for ONFH, especially nonsurgical ones, merit further investigation. To evaluate the combinatorial therapeutic effects of platelet-rich plasma clot releasate (PRCR) and umbilical cord mesenchymal stem cells (UC-MSCs) on glucocorticoid-induced ONFH, a dexamethasone (DEX)-treated cell model and a high-dose methylprednisolone (MPS)-treated rat model were established. Cell counting kit-8 (CCK-8) assay was performed in vitro to determine the optimum dosage of PRCR for UC-MSC viability. The effects of PRCR, UC-MSCs, and PRCR + UC-MSCs on cell viability, apoptosis, migration, and differentiation capacities of DEX-treated bone marrow mesenchymal stem cells (BMSCs) and human umbilical vein endothelial cell (HUVECs) were explored via Transwell assays. Western blotting was conducted to evaluate the expression levels of RUNX2, VEGF, caspase-3, and Bcl-2 in the coculture systems. Ultrasound-guided intra-articular PRCR, UC-MSCs, and PRCR + UC-MSC injections were performed on the ONFH model rats. Microcomputed tomography, histological and immunohistochemical analyses, tartrate-resistant acid phosphatase (TRAP) staining, and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining were used to assess the therapeutic effects of PRCR and UC-MSCs on bone loss and necrosis induced by high-dose MPS. Results of this study revealed that the in vitro application of PRCR, UC-MSCs, and PRCR + UC-MSCs reversed the impaired proliferation and migration capacities and resisted apoptosis of BMSCs and HUVECs induced by DEX. Moreover, the PRCR and UC-MSC application significantly improved the alkaline phosphatase (ALP) and alizarin red (ALR) staining of BMSCs and tube formation capacity of HUVECs and promoted the protein expression of RUNX2 in BMSCs and VEGF in HUVECs. Similarly, in the ONFH rat model, the intra-articular injection of UC-MSCs and PRCR improved the subchondral bone mass parameters; promoted the expression of ALP, RUNX2, and VEGF; suppressed osteoclast overactivity; and resisted cell apoptosis. The combination of PRCR and UC-MSCs shows promising therapeutic effects in treating glucocorticoid-induced ONFH. The current study provides important information on intra-articular therapy, paving the way for the clinical management of ONFH in the future.http://dx.doi.org/10.1155/2022/7432665 |
| spellingShingle | Yanxue Wang Shuo Luan Ze Yuan Shaoling Wang Shengnuo Fan Chao Ma Shaoling Wu The Combined Use of Platelet-Rich Plasma Clot Releasate and Allogeneic Human Umbilical Cord Mesenchymal Stem Cells Rescue Glucocorticoid-Induced Osteonecrosis of the Femoral Head Stem Cells International |
| title | The Combined Use of Platelet-Rich Plasma Clot Releasate and Allogeneic Human Umbilical Cord Mesenchymal Stem Cells Rescue Glucocorticoid-Induced Osteonecrosis of the Femoral Head |
| title_full | The Combined Use of Platelet-Rich Plasma Clot Releasate and Allogeneic Human Umbilical Cord Mesenchymal Stem Cells Rescue Glucocorticoid-Induced Osteonecrosis of the Femoral Head |
| title_fullStr | The Combined Use of Platelet-Rich Plasma Clot Releasate and Allogeneic Human Umbilical Cord Mesenchymal Stem Cells Rescue Glucocorticoid-Induced Osteonecrosis of the Femoral Head |
| title_full_unstemmed | The Combined Use of Platelet-Rich Plasma Clot Releasate and Allogeneic Human Umbilical Cord Mesenchymal Stem Cells Rescue Glucocorticoid-Induced Osteonecrosis of the Femoral Head |
| title_short | The Combined Use of Platelet-Rich Plasma Clot Releasate and Allogeneic Human Umbilical Cord Mesenchymal Stem Cells Rescue Glucocorticoid-Induced Osteonecrosis of the Femoral Head |
| title_sort | combined use of platelet rich plasma clot releasate and allogeneic human umbilical cord mesenchymal stem cells rescue glucocorticoid induced osteonecrosis of the femoral head |
| url | http://dx.doi.org/10.1155/2022/7432665 |
| work_keys_str_mv | AT yanxuewang thecombineduseofplateletrichplasmaclotreleasateandallogeneichumanumbilicalcordmesenchymalstemcellsrescueglucocorticoidinducedosteonecrosisofthefemoralhead AT shuoluan thecombineduseofplateletrichplasmaclotreleasateandallogeneichumanumbilicalcordmesenchymalstemcellsrescueglucocorticoidinducedosteonecrosisofthefemoralhead AT zeyuan thecombineduseofplateletrichplasmaclotreleasateandallogeneichumanumbilicalcordmesenchymalstemcellsrescueglucocorticoidinducedosteonecrosisofthefemoralhead AT shaolingwang thecombineduseofplateletrichplasmaclotreleasateandallogeneichumanumbilicalcordmesenchymalstemcellsrescueglucocorticoidinducedosteonecrosisofthefemoralhead AT shengnuofan thecombineduseofplateletrichplasmaclotreleasateandallogeneichumanumbilicalcordmesenchymalstemcellsrescueglucocorticoidinducedosteonecrosisofthefemoralhead AT chaoma thecombineduseofplateletrichplasmaclotreleasateandallogeneichumanumbilicalcordmesenchymalstemcellsrescueglucocorticoidinducedosteonecrosisofthefemoralhead AT shaolingwu thecombineduseofplateletrichplasmaclotreleasateandallogeneichumanumbilicalcordmesenchymalstemcellsrescueglucocorticoidinducedosteonecrosisofthefemoralhead AT yanxuewang combineduseofplateletrichplasmaclotreleasateandallogeneichumanumbilicalcordmesenchymalstemcellsrescueglucocorticoidinducedosteonecrosisofthefemoralhead AT shuoluan combineduseofplateletrichplasmaclotreleasateandallogeneichumanumbilicalcordmesenchymalstemcellsrescueglucocorticoidinducedosteonecrosisofthefemoralhead AT zeyuan combineduseofplateletrichplasmaclotreleasateandallogeneichumanumbilicalcordmesenchymalstemcellsrescueglucocorticoidinducedosteonecrosisofthefemoralhead AT shaolingwang combineduseofplateletrichplasmaclotreleasateandallogeneichumanumbilicalcordmesenchymalstemcellsrescueglucocorticoidinducedosteonecrosisofthefemoralhead AT shengnuofan combineduseofplateletrichplasmaclotreleasateandallogeneichumanumbilicalcordmesenchymalstemcellsrescueglucocorticoidinducedosteonecrosisofthefemoralhead AT chaoma combineduseofplateletrichplasmaclotreleasateandallogeneichumanumbilicalcordmesenchymalstemcellsrescueglucocorticoidinducedosteonecrosisofthefemoralhead AT shaolingwu combineduseofplateletrichplasmaclotreleasateandallogeneichumanumbilicalcordmesenchymalstemcellsrescueglucocorticoidinducedosteonecrosisofthefemoralhead |